Estimated Savings Under the Medicare High-Value Drug List Model
This cross-sectional study describes potential reductions in out-of-pocket costs for generic medications among Medicare beneficiaries.
Authors
- Christopher Cai (ORCID: https://orcid.org/0000-0002-0567-4691)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Benjamin N. Rome (ORCID: https://orcid.org/0000-0001-5776-3293)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1001/jamainternmed.2024.4846
- Citations
- 1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 1.13